Papp KA - Search Results

1

Strategies for optimizing treatment with efalizumab in moderate to severe psoriasis.

Papp KA, Ho V, Langley R, Lynde C, Poulin Y, Shear N, Toole J, Zip C. Papp KA, et al. J Cutan Med Surg. 2006;9 Suppl 1:26-32. doi: 10.1007/s10227-006-0104-0. J Cutan Med Surg. 2006. PMID: 16633859 Review.

2

Systemic gold therapy.

Papp KA, Shear NH. Papp KA, et al. Clin Dermatol. 1991 Oct-Dec;9(4):535-51. doi: 10.1016/0738-081x(91)90083-w. Clin Dermatol. 1991. PMID: 1822410 Review. No abstract available.

3

Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: a 2-year cohort study.

Ho VC, Griffiths CE, Berth-Jones J, Papp KA, Vanaclocha F, Dauden E, Beard A, Puvanarajan L, Paul C. Ho VC, et al. Among authors: papp ka. J Am Acad Dermatol. 2001 Apr;44(4):643-51. doi: 10.1067/mjd.2001.112400. J Am Acad Dermatol. 2001. PMID: 11260540 Clinical Trial.

4

Randomized placebo-controlled trial of metronidazole 1% cream with sunscreen SPF 15 in treatment of rosacea.

Tan JK, Girard C, Krol A, Murray HE, Papp KA, Poulin Y, Chin DA, Jeandupeux D. Tan JK, et al. Among authors: papp ka. J Cutan Med Surg. 2002 Nov-Dec;6(6):529-34. doi: 10.1007/s10227-001-0144-4. Epub 2002 May 13. J Cutan Med Surg. 2002. PMID: 12001006 Clinical Trial.

5

Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial.

Gordon KB, Papp KA, Hamilton TK, Walicke PA, Dummer W, Li N, Bresnahan BW, Menter A; Efalizumab Study Group. Gordon KB, et al. Among authors: papp ka. JAMA. 2003 Dec 17;290(23):3073-80. doi: 10.1001/jama.290.23.3073. JAMA. 2003. PMID: 14679270 Clinical Trial.

6

Etanercept in psoriasis.

Papp KA. Papp KA. Expert Opin Pharmacother. 2004 Oct;5(10):2139-46. doi: 10.1517/14656566.5.10.2139. Expert Opin Pharmacother. 2004. PMID: 15461549 Review.

7

Efalizumab: Advancing psoriasis management with a novel, targeted T-cell modulator.

Papp KA. Papp KA. Drugs Today (Barc). 2004 Nov;40(11):889-99. doi: 10.1358/dot.2004.40.11.872578. Drugs Today (Barc). 2004. PMID: 15645002 Review.

8

Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trial.

Leonardi CL, Papp KA, Gordon KB, Menter A, Feldman SR, Caro I, Walicke PA, Compton PG, Gottlieb AB; Efalizumab Study Group. Leonardi CL, et al. Among authors: papp ka. J Am Acad Dermatol. 2005 Mar;52(3 Pt 1):425-33. doi: 10.1016/j.jaad.2004.09.029. J Am Acad Dermatol. 2005. PMID: 15761420 Clinical Trial.

9

Integrating biologic agents into management of moderate-to-severe psoriasis: a consensus of the Canadian Psoriasis Expert Panel. February 27, 2004.

Guenther L, Langley RG, Shear NH, Bissonnette R, Ho V, Lynde C, Murray E, Papp K, Poulin Y, Zip C. Guenther L, et al. J Cutan Med Surg. 2004 Sep-Oct;8(5):321-37. doi: 10.1007/s10227-005-0035-1. J Cutan Med Surg. 2004. PMID: 15868311

10

Potential future therapies for psoriasis.

Papp KA. Papp KA. Semin Cutan Med Surg. 2005 Mar;24(1):58-63. doi: 10.1016/j.sder.2005.01.005. Semin Cutan Med Surg. 2005. PMID: 15900800 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

364 results

Search Page

Filters